Arterial Stiffness in Individuals With Breast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age40-69
SponsorHacettepe University
About this trial
The aim of this study was to evaluate vascular toxicity induced by anthracyclines and other anticancer drugs and to measure arterial stiffness in women with breast cancer and, in addition, to evaluate the acute and chronic arterial stiffness responses of upper extremity aerobic exercise training.
Eligibility criteria
Qualifiers
To be between the ages of 40-69,
Baseline left ventricular ejection fraction (LVEF) >50%,
Absence of coronary artery disease and haemodynamically significant valvular heart disease,
Absence of carotid atherosclerotic plaques,
Disqualifiers
Presence of active infection,
Presence of bilateral breast cancer,
History of surgical, neurological or orthopaedic problems that may affect upper extremity functionality other than breast cancer surgery,
Having a neurological disease or other clinical diagnosis that may affect cognitive status,
Trial design
Treatments tested in this trial
- Upper Extremity Aerobic Exercise Training Program
Treatment groups
18 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov